RankAlpha logo
Back to Rankings

OTLK

Outlook TherapeuticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
OTLK vs peer average
28/100
OTLK vs. peer average (F vs. D)
Grade spread
A 1 · B 1 · D 4 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

CHRS is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $226.75M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerCHRSCoherus Oncology
OTLK
Outlook Therapeutics
CHRS
Coherus Oncology
Grade
F
F
Momentum
21
18
Value
41
41
Sentiment
-
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs CHRS

OTLK / CHRS
Grade Position
Below peers
OTLK vs. peer average (F vs. D)
28/100
Momentum
21
OTLK
Value
41
OTLK
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs OTLK
1
CHRS
Coherus Oncology Inc Common
F
20/100
Even
2
TARA
Protara Therapeutics Inc Common
D
40/100
-1
3
AGEN
Agenus Inc Common
D
40/100
-1
4
ACIU
AC Immune SA Common
D
40/100
-1
5
CGEN
Compugen Ltd Common
B
80/100
-3
CHRS is the first peer returned for this comparison set.